Compare Abeona Therapeutics Inc (ABEO) vs First Citizens BancShares Inc (FCNCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs First Citizens BancShares Inc — how do they compare? Abeona Therapeutics Inc trades at $6.36 (market cap $425.47M), while First Citizens BancShares Inc trades at $2,270.44 (market cap $25.26B). The key difference: First Citizens BancShares Inc is far larger — about 59.4× Abeona Therapeutics Inc's market cap, and First Citizens BancShares Inc pays a 0.37% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | FCNCA | |
|---|---|---|
Market Cap | $425.47M | $25.26B |
Sector | Health | Sector/Thematic |
52-Week High | $7.46 | $2.27K |
52-Week Low | $4.17 | $1.64K |
Enterprise Value | $280.37M | — |
Dividend Yield | — | 0.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →
